{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:46:46Z","timestamp":1793137606513,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00223-006-0314-x","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T11:21:06Z","timestamp":1158146466000},"page":"138-144","source":"Crossref","is-referenced-by-count":25,"title":["A Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Zoledronic Acid in the Treatment of Thalassemia-Associated Osteopenia"],"prefix":"10.1007","volume":"79","author":[{"given":"C. P.","family":"Gilfillan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J. S.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. P.","family":"Rodda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. K.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Kean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Obaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,11]]},"reference":[{"key":"314_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2141.2004.05143.x","volume":"127","author":"E Voskaridou","year":"2004","unstructured":"Voskaridou E, Terpos E (2004) New insights into the pathophysiology and management of osteoporosis in patients with beta thalassemia. Br J Haematol 127:127\u2013139","journal-title":"Br J Haematol"},{"key":"314_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0609.1997.tb00729.x","volume":"59","author":"CE Jensen","year":"1997","unstructured":"Jensen CE, Tuck SM, Old J, Morris RW, Yardumian A, De Sanctis V, Hoffbrand AV, Wonke B (1997) Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassemia. Eur J Haematol 59:76\u201381","journal-title":"Eur J Haematol"},{"key":"314_CR3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jcp.35.5.487","volume":"35","author":"RW Chapman","year":"1982","unstructured":"Chapman RW, Hussain MA, Gorman A, Laulicht M, Politis D, Flynn DM, Sherlock S, Hoffbrand AV (1982) Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassemia major and iron overload. J Clin Pathol 35:487\u201391","journal-title":"J Clin Pathol"},{"key":"314_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1385\/BTER:97:3:215","volume":"97","author":"MR Bekheirnia","year":"2004","unstructured":"Bekheirnia MR, Abdollah Shamshirsaz A, Kamgar M, Bouzari N, Erfanzadeh G, Pourzahedgilani N, Tabatabaie SM, Abdollah Shamshirsaz A, Kimiagar M, Ezzati F, Larijani B (2004) Serum zinc and its relation to bone mineral density in beta-thalassemic adolescents. Biol Trace Elem Res 97:215\u2013224","journal-title":"Biol Trace Elem Res"},{"key":"314_CR5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s001980170079","volume":"12","author":"A Lasco","year":"2001","unstructured":"Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N (2001) Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporos Int 12:570\u2013575","journal-title":"Osteoporos Int"},{"key":"314_CR6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00223-004-0024-1","volume":"75","author":"MJ Rogers","year":"2004","unstructured":"Rogers MJ (2004) From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif Tissue Int 75:451\u2013461","journal-title":"Calcif Tissue Int"},{"key":"314_CR7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","volume":"346","author":"IR Reid","year":"2002","unstructured":"Reid IR, Brown JP, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer JP, Kaufman JM, Jaeger P, Body JJ, Brandi ML, Broell J, Di Micco R, Genazzani AR, Felsenberg D, Happ J, Hooper MJ, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier PJ (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653\u2013661","journal-title":"N Engl J Med"},{"key":"314_CR8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1442-200x.2004.02009.x","volume":"47","author":"Y Aydinok","year":"2005","unstructured":"Aydinok Y, Erermis S, Bukosoglu N, Yilmaz D, Solak V (2005) Psychosocial implications of Thalassemia Major. Pediatr Int 47:84\u201389","journal-title":"Pediatr Int"},{"key":"314_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1749-6632.1998.tb10491.x","volume":"850","author":"EP Vichinsky","year":"1998","unstructured":"Vichinsky EP (1998) The morbidity of bone disease in thalassemia. Ann N Y Acad Sci 850:344\u2013348","journal-title":"Ann N Y Acad Sci"},{"key":"314_CR10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2265.1995.tb01876.x","volume":"42","author":"ML Anapliotou","year":"1995","unstructured":"Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M, Dimitriou P (1995) The contribution of hypogonadism to the development of osteoporosis in thalassemia major: new therapeutic approaches. Clin Endocrinol 42:279\u2013287","journal-title":"Clin Endocrinol"},{"key":"314_CR11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00223-002-1044-3","volume":"74","author":"E Carmina","year":"2004","unstructured":"Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, Lo Pinto C, Bruno D, Malizia R, Rini GB (2004) Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcif Tissue Int 74:68\u201371","journal-title":"Calcif Tissue Int"},{"key":"314_CR12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF03344015","volume":"25","author":"A Lasco","year":"2002","unstructured":"Lasco A, Morabito N, Gaudio A, Crisafulli A, Meo A, Denuzzo G, Frisina N (2002) Osteoporosis and beta-thalassemia major: role of the IGF-I\/IGFBP-III axis. J Endocrinol Invest 25:338\u2013344","journal-title":"J Endocrinol Invest"},{"key":"314_CR13","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1210\/jc.2002-021548","volume":"88","author":"P Mahachoklertwattana","year":"2003","unstructured":"Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, Domrongkitchaiporn S, Sirisriro R, Rajatanavin R (2003) Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab 88:3966\u20133972","journal-title":"J Clin Endocrinol Metab"},{"key":"314_CR14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00247-002-0664-0","volume":"32","author":"YL Chan","year":"2002","unstructured":"Chan YL, Pang LM, Chik KW, Cheng JC, Li CK (2002) Patterns of bone diseases in transfusion-dependent homozygous thalassemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia. Pediatr Radiol 32:492\u2013497","journal-title":"Pediatr Radiol"},{"key":"314_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2141.2001.02549.x","volume":"112","author":"E Voskaridou","year":"2001","unstructured":"Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A, Loukopoulos D (2001) Bone resorption is increased in young adults with thalassemia major. Br J Haematol 112:36\u201341","journal-title":"Br J Haematol"},{"key":"314_CR16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1359\/jbmr.040113","volume":"19","author":"N Morabito","year":"2004","unstructured":"Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M, La Rosa M, Guarino R, Meo A, Frisina N (2004) Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J Bone Miner Res 19:722\u2013727","journal-title":"J Bone Miner Res"},{"key":"314_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","volume":"11","author":"J Reginster","year":"2000","unstructured":"Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, Lund B, Ethgen D, Pack S, Roumagnac I, Eastell R (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11:83\u201391","journal-title":"Osteoporos Int"},{"key":"314_CR18","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","volume":"85","author":"DM Black","year":"2000","unstructured":"Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR; Fracture Intervention Trial (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85:4118\u20134124","journal-title":"J Clin Endocrinol Metab"},{"key":"314_CR19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s001980200087","volume":"13","author":"N Morabito","year":"2002","unstructured":"Morabito N, Lasco A, Gaudio A, Crisafulli A, Di Pietro C, Meo A, Frisina N (2002) Bisphosphonates in the treatment of thalassemia-induced osteoporosis. Osteoporos Int 13:644\u2013649","journal-title":"Osteoporos Int"},{"key":"314_CR20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.2003.04657.x","volume":"123","author":"E Voskaridou","year":"2003","unstructured":"Voskaridou E, Terpos E, Spina G, Palermos J, Rahemtulla A, Loutradi A, Loukopoulos D (2003) Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassemia. Br J Haematol 123:730\u2013737","journal-title":"Br J Haematol"},{"key":"314_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2141.2004.04871.x","volume":"125","author":"V Perifanis","year":"2004","unstructured":"Perifanis V, Vyzantiadis T, Vakalopoulou S, Tziomalos K, Garypidou V, Athanassiou-Metaxa M, Harsoulis F (2004) Treatment of beta-thalassemia-associated osteoporosis with zoledronic acid [letter]. Br J Haematol 125:91\u201392","journal-title":"Br J Haematol"},{"key":"314_CR22","first-page":"377","volume":"7","author":"LS Rosen","year":"2001","unstructured":"Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein M, Coleman RE, Reitsma DJ, Seaman JJ, Chen BL, Ambros Y (2001) Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J 7:377\u2013387","journal-title":"Cancer J"},{"key":"314_CR23","unstructured":"Gilfillan CP, Psihogios V, Strauss BJ, Bowden DK, Rodda CP (1999) Bone mineral density in homozygous \u03b2-thalassemia: relationship to anthropometry and gonadal status. Abstract and oral presentation. ANZBMS Annual Scientific Meeting, Cairns, Australia; Aug 14\u201318"},{"key":"314_CR24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1196\/annals.1345.063","volume":"1054","author":"MG Vogiatzi","year":"2005","unstructured":"Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, Giardina PJ (2005) Low bone mineral density in adolescents with \u03b2-thalassemia. Ann N Y Acad Sci 1054:462\u2013466","journal-title":"Ann N Y Acad Sci"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-006-0314-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0314-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:37:51Z","timestamp":1558683471000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-006-0314-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1007\/s00223-006-0314-x","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}